Abstract
Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have